https://ceo.ca/@newswire/quest-pharmatech-announces-results-from-agm-99616

On a corporate matter, Quest announces the granting of 1,300,000 stock options to Directors and Officers, all at a volume weighted average exercise price of $0.09 per common share, expiring 10 years from the date of grant, subject to TSX Venture Exchange approval.

 You'd think they would take the opportunity to acknowledge the elephant in the room? Nah. :)